Determining the optimal steroid treatment regimen for COPD exacerbations : A review of the literature
No Thumbnail Available
Authors
Meeting name
Sponsors
Date
Journal Title
Format
Article
Subject
Abstract
In reviewing the literature, there is not a uniform approach to corticosteroid treatment when managing patients with COPD exacerbations. In general it is important to remember: Oral corticosteroids are as effective as IV corticosteroids in the management of most COPD exacerbations not requiring ICU admission. -- Short courses of prednisone (40mg daily for 5 days) are appropriate for most COPD exacerbations. -- Patients with frequent exacerbations of 2 or more per year or patients on chronic steroids may require a prolonged course of treatment. -- ICU patients have largely been excluded or not specifically studied in most analyses. Available literature shows that this subset of patients may benefit most from high-dose IV therapy for the first few days of treatment. Once patients are clinically improving, it would be reasonable to deescalate to oral therapy to limit unnecessary exposure.
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
